Trophoblastic neoplasm

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Trophoblastic neoplasm | |
|---|---|
| Synonyms | Gestational trophoblastic disease |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Abnormal vaginal bleeding, pelvic pain, enlarged uterus |
| Complications | Metastasis, hemorrhage, infertility |
| Onset | Reproductive age |
| Duration | Varies |
| Types | Hydatidiform mole, Choriocarcinoma, Placental site trophoblastic tumor, Epithelioid trophoblastic tumor |
| Causes | Abnormal fertilization |
| Risks | Prior molar pregnancy, advanced maternal age, history of miscarriage |
| Diagnosis | Ultrasound, hCG levels, histopathology |
| Differential diagnosis | Ectopic pregnancy, miscarriage, ovarian tumor |
| Prevention | None |
| Treatment | Chemotherapy, surgery |
| Medication | Methotrexate, Dactinomycin |
| Prognosis | Generally good with treatment |
| Frequency | Rare |
| Deaths | N/A |
A group of rare tumors involving trophoblastic tissue
Trophoblastic neoplasms are a group of rare tumors that involve the trophoblast, the layer of cells that surrounds the embryo and contributes to the formation of the placenta. These neoplasms are part of a broader category known as gestational trophoblastic disease (GTD), which includes both benign and malignant conditions.
Types[edit]
Trophoblastic neoplasms can be classified into several types, each with distinct characteristics and clinical implications:
Hydatidiform mole[edit]
A hydatidiform mole is a benign form of trophoblastic disease that can be either complete or partial. It is characterized by abnormal growth of trophoblastic tissue and can lead to persistent gestational trophoblastic disease if not treated.
Invasive mole[edit]
An invasive mole is a type of trophoblastic neoplasm that occurs when a hydatidiform mole invades the muscular layer of the uterus. It can cause significant bleeding and may require chemotherapy for treatment.
Choriocarcinoma[edit]
Choriocarcinoma is a highly malignant form of trophoblastic neoplasm that can occur after any type of pregnancy. It is characterized by rapid growth and early metastasis, often to the lungs and brain. Treatment typically involves chemotherapy.

Placental site trophoblastic tumor[edit]
A placental site trophoblastic tumor (PSTT) is a rare form of trophoblastic neoplasm that arises from the placental implantation site. It is less responsive to chemotherapy compared to other types and may require surgical intervention.
Epithelioid trophoblastic tumor[edit]
An epithelioid trophoblastic tumor (ETT) is another rare variant that resembles carcinoma and can occur years after a normal pregnancy. It is often treated with surgery and chemotherapy.
Diagnosis[edit]
Diagnosis of trophoblastic neoplasms typically involves a combination of clinical evaluation, imaging studies, and laboratory tests. Measurement of human chorionic gonadotropin (hCG) levels is crucial, as elevated levels can indicate the presence of trophoblastic disease.
Treatment[edit]
Treatment strategies for trophoblastic neoplasms depend on the type and stage of the disease. Chemotherapy is the mainstay of treatment for malignant forms such as choriocarcinoma, while surgical intervention may be necessary for localized tumors like PSTT and ETT.
Prognosis[edit]
The prognosis for patients with trophoblastic neoplasms varies based on the type and extent of the disease. Early detection and treatment generally lead to favorable outcomes, especially for choriocarcinoma, which is highly sensitive to chemotherapy.
See also[edit]
References[edit]
- Seckl, M. J., Sebire, N. J., & Berkowitz, R. S. (2010). Gestational trophoblastic disease. The Lancet, 376(9742), 717-729.
- Lurain, J. R. (2010). Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. American Journal of Obstetrics and Gynecology, 203(1), 11-18.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian